83 related articles for article (PubMed ID: 25044117)
1. Cilostazol prevents the degradation of collagen type II in human chondrocytes.
Wang W; Kang W; Tang Q; Yao G; Chen Y; Cheng B; Kong K
Biochem Biophys Res Commun; 2014 Aug; 451(3):352-5. PubMed ID: 25044117
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib prevents the expression of MMP-13 and the degradation of collagen type 2 in human chondrocytes.
Hu W; Zhang W; Li F; Guo F; Chen A
Biochem Biophys Res Commun; 2014 Sep; 452(3):526-30. PubMed ID: 25172660
[TBL] [Abstract][Full Text] [Related]
3. The protective effects of Donepezil (DP) against cartilage matrix destruction induced by TNF-α.
Zhang D; Zhou Y
Biochem Biophys Res Commun; 2014 Nov; 454(1):115-8. PubMed ID: 25450366
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Lu H; Zeng C; Zhao H; Lian L; Dai Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):323-8. PubMed ID: 24657155
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin prevents articular cartilage matrix destruction in human chondrocytes.
Liu J; Cao L; Gao X; Chen Z; Guo S; He Z; Qian Y; Yu Y; Wang G
Biomed Pharmacother; 2018 Feb; 98():651-655. PubMed ID: 29291551
[TBL] [Abstract][Full Text] [Related]
6. Interferonregulatoryfactor-8(IRF-8) regulates the expression of matrix metalloproteinase-13 (MMP-13) in chondrocytes.
Yang Q; Ding W; Cao Y; Zhou Y; Ni S; Shi T; Fu W
Cell Stress Chaperones; 2018 May; 23(3):393-398. PubMed ID: 29247272
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-Like Factor 2 Regulates Degradation of Type II Collagen by Suppressing the Expression of Matrix Metalloproteinase (MMP)-13.
Yuan Y; Tan H; Dai P
Cell Physiol Biochem; 2017; 42(6):2159-2168. PubMed ID: 28873368
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin prevents cartilage matrix destruction via regulating matrix metalloproteinases.
Wu Y; Wu T; Xu B; Xu X; Chen H; Li X
Biochem Biophys Res Commun; 2017 May; 486(3):601-606. PubMed ID: 28238786
[TBL] [Abstract][Full Text] [Related]
9. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
[TBL] [Abstract][Full Text] [Related]
10. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes.
Chen YJ; Tsai KS; Chan DC; Lan KC; Chen CF; Yang RS; Liu SH
J Orthop Res; 2014 Apr; 32(4):573-80. PubMed ID: 24375705
[TBL] [Abstract][Full Text] [Related]
11. Effects of diallyl sulphide in chondrocyte and cartilage in experimental osteoarthritis in rabbit.
Chen WP; Tang JL; Bao JP; Hu PF; Yu C; Shi ZL; Wu LD
Phytother Res; 2011 Mar; 25(3):351-6. PubMed ID: 20683842
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.
Ahmad R; Qureshi HY; El Mabrouk M; Sylvester J; Ahmad M; Zafarullah M
Ann Rheum Dis; 2007 Jun; 66(6):782-9. PubMed ID: 17179173
[TBL] [Abstract][Full Text] [Related]
13. Human osteoarthritic chondrocytes are impaired in matrix metalloproteinase-13 inhibition by IFN-gamma due to reduced IFN-gamma receptor levels.
Ahmad R; El Mabrouk M; Sylvester J; Zafarullah M
Osteoarthritis Cartilage; 2009 Aug; 17(8):1049-55. PubMed ID: 19285161
[TBL] [Abstract][Full Text] [Related]
14. α-Lipoic acid (α-LA) inhibits the transcriptional activity of interferon regulatory factor 1 (IRF-1) via SUMOylation.
Sun T; Gao F; Lin X; Yu R; Zhao Y; Luan J; Li H; Song M
Toxicol In Vitro; 2014 Oct; 28(7):1242-8. PubMed ID: 24975507
[TBL] [Abstract][Full Text] [Related]
15. Edaravone suppresses degradation of type II collagen.
Huang C; Liao G; Han J; Zhang G; Zou B
Biochem Biophys Res Commun; 2016 May; 473(4):840-844. PubMed ID: 27037019
[TBL] [Abstract][Full Text] [Related]
16. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
18. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
19. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes.
Rosa SC; Rufino AT; Judas FM; Tenreiro CM; Lopes MC; Mendes AF
J Cell Biochem; 2011 Oct; 112(10):2813-24. PubMed ID: 21608018
[TBL] [Abstract][Full Text] [Related]
20. Effects of controlled released BMP-7 on markers of inflammation and degradation during the cultivation of human osteoarthritic chondrocytes.
Gavenis K; Pufe T; Brandenburg LO; Schiffl K; Schmidt-Rohlfing B
J Biomater Appl; 2011 Nov; 26(4):419-33. PubMed ID: 20624843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
